![](/img/cover-not-exists.png)
Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy
Yosuke Horita, Y. Yamada, Y. Hirashima, K. Kato, T. Nakajima, T. Hamaguchi, Y. ShimadaVolume:
65
Language:
english
Pages:
5
DOI:
10.1007/s00280-009-1051-4
Date:
February, 2010
File:
PDF, 529 KB
english, 2010